APA (7th ed.) Citation

Pangarsa, E. A., Astuti, P. D., Rizky, D., Tandarto, K., Setiawan, B., Winarno, A. A., . . . Suharti, C. (2024). First-line endocrine therapy combined with CDK 4/6 inhibitor in disseminated carcinomatosis of bone marrow (DCBM) luminal breast cancer: A case report. Journal of Medical Case Reports, 18(1), 1. https://doi.org/10.1186/s13256-024-04922-4

Chicago Style (17th ed.) Citation

Pangarsa, Eko Adhi, Putri Dwi Astuti, Daniel Rizky, Kevin Tandarto, Budi Setiawan, Andreas Agung Winarno, Damai Santosa, and Catharina Suharti. "First-line Endocrine Therapy Combined with CDK 4/6 Inhibitor in Disseminated Carcinomatosis of Bone Marrow (DCBM) Luminal Breast Cancer: A Case Report." Journal of Medical Case Reports 18, no. 1 (2024): 1. https://doi.org/10.1186/s13256-024-04922-4.

MLA (9th ed.) Citation

Pangarsa, Eko Adhi, et al. "First-line Endocrine Therapy Combined with CDK 4/6 Inhibitor in Disseminated Carcinomatosis of Bone Marrow (DCBM) Luminal Breast Cancer: A Case Report." Journal of Medical Case Reports, vol. 18, no. 1, 2024, p. 1, https://doi.org/10.1186/s13256-024-04922-4.